Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Sodium aurothiomalate
Drug ID BADD_D02033
Description Sodium aurothiomalate is a gold compound that is used for its immunosuppressive anti-rheumatic effects. Gold Sodium Thiomalate is supplied as a solution for intramuscular injection containing 50 mg of Gold Sodium Thiomalate per mL. It is most effective in active progressive rheumatoid arthritis and of little or no value in the presence of extensive deformities or in the treatment of other forms of arthritis.
Indications and Usage A disease-modifying antirheumatic drug (DMARD) indicated for the symptomatic treatment of arthritis.
Marketing Status approved; investigational
ATC Code M01CB01
DrugBank ID DB09276
KEGG ID D00992
MeSH ID D006052
PubChem ID 22318
TTD Drug ID D0FH7C
NDC Product Code Not Available
UNII HRS6S09A0H
Synonyms Gold Sodium Thiomalate | Sodium Thiomalate, Gold | Sodium Aurothiomalate | Aurothiomalate, Sodium | Mercaptobutanedioic Acid Monogold(1+) Sodium Salt | Sodium Gold Thiomalate | Gold Thiomalate, Sodium | Sodium Thiomalatoaurate | Thiomalatoaurate, Sodium | Gold Disodium Thiomalate, Monohydrate | Gold Thiomalate | Thiomalate, Gold | Gold Thiomalic Acid | Aurolate | Monogold (1+) Disodium Thiomalate | Myochrysine | Myocrisin | Miocrisin | Myocrysine | Tauredon | Aurothiomalate | Miocrin
Chemical Information
Molecular Formula C4H3AuNa2O4S
CAS Registry Number 12244-57-4
SMILES C(C(C(=O)[O-])[S-])C(=O)[O-].[Na+].[Na+].[Au+]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Erythema23.03.06.001--Not Available
Eye disorder06.08.03.001--Not Available
Feeling abnormal08.01.09.014--Not Available
Fibrosis08.03.01.001--Not Available
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Gastrointestinal disorder07.11.01.001--Not Available
Glomerulonephritis10.02.01.006; 20.05.01.001--Not Available
Granulocytopenia01.02.03.003--Not Available
Guillain-Barre syndrome17.09.01.001; 11.07.01.001; 10.04.10.005--
Haematuria21.10.01.018; 24.07.01.047; 20.02.01.006--
Hallucination19.10.04.003--
Headache17.14.01.001--
Hepatic failure09.01.03.002--
Hepatitis09.01.07.004--Not Available
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypoplastic anaemia01.03.03.006--Not Available
Interstitial lung disease22.01.02.003; 10.02.01.033--Not Available
Iritis10.02.01.022; 06.04.03.002--Not Available
Jaundice23.03.03.030; 09.01.01.004; 01.06.04.004--Not Available
Jaundice cholestatic09.01.01.005--Not Available
Leukopenia01.02.02.001--Not Available
Loss of consciousness17.02.04.004--Not Available
Lung infiltration22.01.02.004--Not Available
Malaise08.01.01.003--
Metal poisoning12.03.01.049--Not Available
Nausea07.01.07.001--
Nephritis20.05.02.001--Not Available
Nephropathy20.05.03.001--Not Available
Nephrotic syndrome20.05.01.002--
Neuropathy peripheral17.09.03.003--Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages